SCHEMBL4132207

SCHEMBL4132207

COc1cccc(C(=O)c2cc(Cl)ccc2N)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.56
RORC P51449 3/20 0.49
RORB Q92753 3/20 0.49
KCNMA1 Q12791 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HIF1A Q16665 1/20 0.46
FADS1 O60427 1/20 0.45
KLKB1 P03952 1/20 0.44
MAPK13 O15264 1/20 0.44
MAPK12 P53778 1/20 0.44
MAPK11 Q15759 1/20 0.44
MAPK14 Q16539 1/20 0.44
ABL1 P00519 1/20 0.43
TAS1R3 Q7RTX0 2/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
TAS1R2 Q8TE23 1/20 0.43
KLK1 P06870 1/20 0.42
KLK5 Q9Y337 1/20 0.42
G6PD P11413 1/20 0.42
CRHBP P24387 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4125266 0.87 RECQL (0.57) RECQLRORCRORBKCNMA1KDM4E
SCHEMBL2705425 0.87 RECQL (0.65) RECQLRORCRORBKCNMA1KDM4E
SCHEMBL635552 0.86 RECQL (0.56) RECQLRORCRORBKCNMA1KDM4E
SCHEMBL4124662 0.86 RECQL (0.56) RECQLRORCRORBKCNMA1KDM4E
SCHEMBL15641368 0.85 RECQL (0.55) RECQLRORCRORBKCNMA1KDM4E
SCHEMBL9162777 0.84 MAPT (0.52) RECQLKCNMA1KDM4EABL1
SCHEMBL4117580 0.83 RECQL (0.52) RECQLRORCRORBKCNMA1KDM4E
SCHEMBL4115238 0.83 RECQL (0.52) RECQLRORCRORBKCNMA1KDM4E
SCHEMBL480276 0.82 KDM4E (0.59) RECQLKDM4EKLKB1TAS1R3TAS1R1
SCHEMBL4124299 0.81 RECQL (0.50) RECQLRORCRORBKCNMA1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR RECQL 271/4885RORC 2588/4885RORB 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.